The “Ozempic Effect” and What It Means for Walmart’s Apparel Business

Shifting Size Curves in U.S. Apparel

Weight-loss medications such as Ozempic, Wegovy, and Zepbound are reshaping demand for apparel sizes. In New York, a recent Impact Analytics study showed sales of women’s small button-down shirts increased about 12 percent over the past two years, while sales of large to XXL declined nearly 11 percent. Resale store owners from Florida to Missouri report that larger sizes, once scarce, are now showing up in greater volume, with smaller sizes selling more quickly.

At the retail level, apparel buyers are reconsidering long-established size ratios. Traditionally, large and XL were ordered in greater proportion. Now, many merchants are adjusting more frequently than the usual six- to nine-month cycle, with tighter runs of extended sizes in stores and some styles pushed online to manage inventory risk. This shift is not yet universal, but it is evident in several major categories.

What This Means for Walmart

For Walmart, which sells more apparel units in the U.S. than any other retailer, the trend creates both risk and opportunity.

Opportunities:

• A wave of wardrobe refreshes is coming. Consumers using GLP-1s often move through multiple sizes in quick succession, which drives purchases of basics such as jeans, T-shirts, and activewear. Walmart can capture share by emphasizing value and convenience in these staples.
• Omnichannel flexibility is a strength. Extended sizes that move more slowly can be shifted online, where assortment can be broad without crowding store racks. This reduces markdown exposure while still serving demand.
• Quick-turn fashion programs provide an opening. Customers losing weight are often eager to try new styles. Walmart’s ability to respond quickly through private brands and supplier partnerships positions it to meet that demand.

Risks:

• Pulling back too far from plus sizes could backfire. A significant share of U.S. shoppers still rely on extended and tall sizes. Business Insider and Modern Retail have noted that availability of inclusive apparel has already tightened in some channels, and stepping back further could alienate a loyal base.
• Apparel supply chains cannot pivot overnight. If Walmart adjusts too slowly, it risks excess inventory in larger sizes and stockouts in smaller ones. If it adjusts too aggressively, it could miss steady demand among customers who remain plus size.

A Balanced Path Forward

The long-term outlook is still uncertain. Only about 12 percent of U.S. adults report having used GLP-1 medications so far, with another 14 percent expressing interest, according to RAND. Even with recent price cuts, these drugs remain expensive for many Americans, and uptake will depend on insurance coverage and competitive pricing. That means Walmart must avoid assuming a wholesale shrinkage of the plus-size market.

A practical approach is to strengthen real-time monitoring of size performance, negotiate more flexible sourcing contracts, and pilot assortment changes in select markets before scaling them nationwide. Maintaining inclusivity in tall and plus sizing is also critical. As one apparel founder cautioned, weight loss may shrink waistlines, but it does not reduce height, and tall customers still need properly fitted clothing.

Closing Perspective

The “Ozempic effect” is not a passing fad but neither is it a complete reshaping of the U.S. apparel market. For Walmart and its suppliers, the priority is balance: lean into the opportunity for smaller sizes and repeat purchases while preserving the breadth that makes the company a destination for every body type. The retailers that strike that balance will be best positioned to win share as America’s size curve continues to evolve.

Winning With Walmart

Winning With Walmart is an independent platform for suppliers, sellers, solution providers, and industry experts.

Articles are developed by staff editors, contributing experts, and trusted partners.

Some are researched and drafted with the assistance of AI tools and are reviewed, fact-checked, and edited by Winning With Walmart editors before publication.

Editorial judgment, sourcing decisions, and final approval rest with the publication's human editors in every case.

We are committed to accuracy and fairness. If you believe this article contains an error, we welcome your feedback.